Search for: "Eli Lilly "
Results 1041 - 1060
of 2,131
Sorted by Relevance
|
Sort by Date
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of generic Strattera:… [read post]
1 Mar 2012, 9:35 am
Eli Lilly & Co. v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
1 Mar 2012, 10:11 am
Eli Lilly & Co. v. [read post]
3 Nov 2010, 1:21 am
Highlights this week included: US Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) Gemzar (Gemcitabine) – US: CAFC denies en banc rehearing of ‘distorted’ law of double-patenting: Sun Pharmaceuticals v Eli Lilly (Peter Zura’s 271 Patent… [read post]
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
12 Dec 2014, 10:29 pm
Judge Sleet found issues with four of the five Cubist patents related to daptomycin.As to the '967 patent:The court notes initially that several of Cubist's counterarguments as to whythe Woodworm article does not anticipate are more appropriately directed at anobviousness inquiry. [read post]
17 Jul 2017, 3:39 pm
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on its behalf in the coming weeks, months and years. [read post]
14 Oct 2015, 6:24 am
New rules on corporate lawsuits could result in more claims by foreign corporations against the Canadian government over national policies or court decisions (pharmaceutical giant Eli Lilly is already suing the government for $500 million over Canadian patent rulings) and an extension in the term of copyright beyond the international standard would lock down the public domain for decades and potentially cost Canadians hundreds of millions of dollars per year. [read post]
15 Apr 2021, 1:42 pm
But the pushback of these action dates for AbbVie’s Rinvoq, Pfizer’s Xeljanz and abrocitinib, and Eli Lilly’s Olumiant may be a sign that the FDA is preparing to hold an advisory committee of outside experts to review the risk/benefit profiles of JAK inhibitors for atopic dermatitis, according to Leerink analyst Geoffrey Porges. [read post]
21 Feb 2024, 6:26 pm
Ashton said.But now, that patient-doctor conversation has gone virtual.Last December, pharmaceutical company Eli Lilly announced its Zepbound injection – the sister medicine of its diabetes drug Mounjaro. [read post]
4 Aug 2010, 12:21 am
Eli Lilly (Orange Book Blog) (Patently-O) (Gray on Claims) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
9 Feb 2009, 11:32 pm
Of Cymbalta, from biz.yahoo :US drug major Eli Lilly, continuing its fight against the generic launch of its second-largest selling drug, Cymbalta, sued Sun Pharma on December 4. [read post]
4 Jan 2013, 4:15 am
Eli Lilly paid $1.4 billion. [read post]
31 Aug 2017, 9:53 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
17 Sep 2022, 8:19 am
You just liked "ribs," but your feeling of liking it came, I'll bet, from having seen it so recently.And here's the Wikipedia entry for Tuinal, a Eli Lilly sleeping pill introduced in the late 1940s and now discontinued:Tuinal saw widespread abuse as a recreational drug from the 1960s through the 1980s. [read post]
5 Oct 2020, 5:17 am
Syoma the cat relaxing after a good read of TerrellImage: Olga GurgulaA significantly updated Chapter 9 on the construction of specifications and claims contains, inter alia, a detailed explanation on the modern approach and the Actavis v Eli Lilly case. [read post]
16 Feb 2016, 1:43 am
Mr Justice Arnold handed down his decision in the latest Eli Lilly and Actavis battle concerning lung cancer treatment pemetrexed disodium, in Actavis v Lilly [2016] EWHC 234, and Annsley takes the floor to recount this romantic, patent story,**********PREVIOUSLY, ON NEVER TOO LATENever too late 82 [week ending on Sunday 7 January] – PhD Student Seminar at CIPA | IP meets Antimonopoly law in Japan | German Federal Patent… [read post]
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly – A look back at the… [read post]
